Drug Profile
AVE 0847
Alternative Names: AVE0847Latest Information Update: 07 Apr 2008
Price :
$50
*
At a glance
- Originator Genfit; sanofi-aventis
- Developer sanofi-aventis
- Class Antihyperglycaemics
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Lipid metabolism disorders; Type 2 diabetes mellitus
Most Recent Events
- 04 Apr 2008 Discontinued - Phase-II for Lipid metabolism disorders in France (unspecified route)
- 04 Apr 2008 Discontinued - Phase-II for Type-2 diabetes mellitus in France (unspecified route)
- 01 Mar 2005 Phase-I clinical trials in Lipid metabolism disorders in France (unspecified route)